KDIGO:在快速变化的领域中导航
KDIGO制定循证临床实践指南以改善全球肾脏病诊疗,已发布17部指南,其中7部至少全面更新一次。为更快响应临床试验与药物批准,KDIGO对部分指南采用模块化更新,如2021肾小球疾病指南自2024年起分章节更新已发布4章。
要点
- KDIGO已发布17部指南,7部至少全面更新一次。
- 部分指南改为模块化更新,如肾小球疾病指南分章节发布。
- 配套争议会议与实施活动支持指南制定与推广。
核心结论
- KDIGO通过模块化更新等策略适应肾脏病领域快速进展,提供及时可信的指导。
研究设计与样本
- 本文为KDIGO组织方法学综述,总结其指南制定与更新流程及配套举措。
主要发现
- KDIGO已发布17部指南,其中7部至少全面更新一次。
- 2021肾小球疾病指南采用逐章更新,自2024年起已发布4章。
临床怎么用
- 肾内科医生可关注KDIGO模块化更新章节,及时获取最新推荐。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Kidney Disease: Improving Global Outcomes (KDIGO) develops evidence-based clinical practice guidelines to improve care for people with kidney disease worldwide. KDIGO has produced 17 guidelines across kidney care, and 7 of these have been updated comprehensively at least once. Historically, guidelines were revised in their entirety when novel therapies or treatment paradigms emerged-a process requiring years to complete. To respond more dynamically to accelerated clinical trial results and drug approvals, KDIGO recently adopted a modular update approach for some guidelines. For example, the 2021 Glomerular Diseases Guideline is being updated chapter by chapter, with 4 chapters published since 2024. To support guideline development and promote implementation, additional KDIGO initiatives include Controversies Conferences, which convene global experts to synthesize current knowledge and identify research priorities, and implementation activities such as regional presentations and summits. The pace of scientific advances in kidney disease has never been faster, and KDIGO continues to adapt its programmatic approach to meet the need for trusted, timely guidance.
引用
- Grams ME, Jadoul M. Kidney Disease: Improving Global Outcomes (KDIGO): navigating a rapidly changing landscape. Kidney Int. 2026. PMID: 41778929. doi:10.1016/j.kint.2025.12.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。